NEW YORK, Aug. 3, (GenomeWeb News) - Bruker Biosciences today reported increased revenues for the second quarter, amid widened net losses.
The Billerica, Mass., company reported $64.1 million in revenues for the quarter ended June 30, compared to $60.9 million for the comparable period last year. Losses totaled $4.7 million, or .05 per share, up from $1.6 million, or .02 per share, for the year-ago quarter.
The company warned of lower-than expected revenues for the quarter July 15.
R& D expenses increased to $10.9 million, compared to $9.7 million for the second quarter of 2003.
As of June 30, the company had $79.2 millon in cash and short-term investments, compared to $76.8 million as of December 31, 2003.